BRIDGEWAY CAPITAL MANAGEMENT, LLC - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 24 filers reported holding TREVI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$406,529
-8.8%
186,4810.0%0.01%
-9.1%
Q2 2023$445,690
+27.9%
186,481
-1.0%
0.01%
+22.2%
Q1 2023$348,540
-13.3%
188,400
-9.6%
0.01%
-10.0%
Q4 2022$402,212
+64.2%
208,400
+30.8%
0.01%
+42.9%
Q3 2022$245,000
-14.9%
159,300
+55.3%
0.01%0.0%
Q2 2022$288,000
+74.5%
102,600
+36.8%
0.01%
+133.3%
Q1 2022$165,000
+179.7%
75,0000.0%0.00%
+200.0%
Q4 2021$59,000
+25.5%
75,000
+116.8%
0.00%0.0%
Q3 2021$47,000
-39.7%
34,6000.0%0.00%0.0%
Q2 2021$78,000
-73.9%
34,600
-68.4%
0.00%
-83.3%
Q1 2021$299,000
+23.6%
109,600
+9.6%
0.01%
+20.0%
Q4 2020$242,000
-40.0%
100,0000.0%0.01%
-44.4%
Q3 2020$403,000
-38.8%
100,0000.0%0.01%
-30.8%
Q2 2020$658,000
+166.4%
100,000
+33.3%
0.01%
+116.7%
Q1 2020$247,000
-12.1%
75,0000.0%0.01%
+50.0%
Q4 2019$281,00075,0000.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 11,370,376$24,787,4201.91%
Fairmount Funds Management LLC 5,163,287$11,255,9661.35%
Opaleye Management Inc. 1,705,900$3,718,8621.21%
Frazier Life Sciences Management, L.P. 6,881,090$15,000,7761.00%
VR Adviser, LLC 3,422,397$7,460,8250.78%
SILVERARC CAPITAL MANAGEMENT, LLC 927,415$2,021,7650.61%
Rubric Capital Management LP 5,684,420$12,392,0360.46%
Tejara Capital Ltd 180,227$392,8950.22%
PFS Partners, LLC 100,000$218,0000.19%
WealthTrust Axiom LLC 93,500$203,8300.07%
View complete list of TREVI THERAPEUTICS INC shareholders